Mural Oncology downgraded by Raymond James with a new price target
$MURA
Biotechnology: Pharmaceutical Preparations
Health Care
Raymond James downgraded Mural Oncology from Strong Buy to Outperform and set a new price target of $18.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/25/2025 | Overweight → Equal-Weight | Morgan Stanley | |
| 3/25/2025 | $18.00 | Strong Buy → Outperform | Raymond James |
| 6/28/2024 | $15.00 | Buy | Rodman & Renshaw |
| 4/4/2024 | $13.00 | Overweight | Morgan Stanley |